Eric Olson

Array ( [id] => 6413910 [patent_doc_number] => 20100166867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Novel administration form of osteogenic protein complexes' [patent_app_type] => utility [patent_app_number] => 12/591442 [patent_app_country] => US [patent_app_date] => 2009-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20608 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166867.pdf [firstpage_image] =>[orig_patent_app_number] => 12591442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6413910 [patent_doc_number] => 20100166867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Novel administration form of osteogenic protein complexes' [patent_app_type] => utility [patent_app_number] => 12/591442 [patent_app_country] => US [patent_app_date] => 2009-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20608 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20100166867.pdf [firstpage_image] =>[orig_patent_app_number] => 12591442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6231606 [patent_doc_number] => 20100184732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'METHOD OF LONG-TERM TREATMENT OF GRAFT-VERSUS-HOST DISEASE USING TOPICAL ACTIVE CORTICOSTEROIDS' [patent_app_type] => utility [patent_app_number] => 12/621436 [patent_app_country] => US [patent_app_date] => 2009-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7334 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184732.pdf [firstpage_image] =>[orig_patent_app_number] => 12621436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6220081 [patent_doc_number] => 20100055176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'Method of Treating Fibromyalgia or Associated Functional Symptoms of Fibromyalgia' [patent_app_type] => utility [patent_app_number] => 12/618388 [patent_app_country] => US [patent_app_date] => 2009-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4193 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055176.pdf [firstpage_image] =>[orig_patent_app_number] => 12618388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4628871 [patent_doc_number] => 08007752 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'Process for preparing oral calcium compositions' [patent_app_type] => utility [patent_app_number] => 12/591230 [patent_app_country] => US [patent_app_date] => 2009-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6004 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/007/08007752.pdf [firstpage_image] =>[orig_patent_app_number] => 12591230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8340162 [patent_doc_number] => 08242086 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-14 [patent_title] => 'Methods and compositions for treating disorders caused by a deficiency in a gene product of a CLN gene' [patent_app_type] => utility [patent_app_number] => 12/617318 [patent_app_country] => US [patent_app_date] => 2009-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 18860 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12617318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8675494 [patent_doc_number] => 08383606 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-26 [patent_title] => 'Sulfoalkyl ether cyclodextrin compositions' [patent_app_type] => utility [patent_app_number] => 12/613103 [patent_app_country] => US [patent_app_date] => 2009-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 28842 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12613103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8675494 [patent_doc_number] => 08383606 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-26 [patent_title] => 'Sulfoalkyl ether cyclodextrin compositions' [patent_app_type] => utility [patent_app_number] => 12/613103 [patent_app_country] => US [patent_app_date] => 2009-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 28842 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12613103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8675494 [patent_doc_number] => 08383606 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-26 [patent_title] => 'Sulfoalkyl ether cyclodextrin compositions' [patent_app_type] => utility [patent_app_number] => 12/613103 [patent_app_country] => US [patent_app_date] => 2009-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 28842 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12613103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8675494 [patent_doc_number] => 08383606 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-26 [patent_title] => 'Sulfoalkyl ether cyclodextrin compositions' [patent_app_type] => utility [patent_app_number] => 12/613103 [patent_app_country] => US [patent_app_date] => 2009-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 28842 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12613103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9345225 [patent_doc_number] => 08664373 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-04 [patent_title] => 'Method for producing sophorose lipid' [patent_app_type] => utility [patent_app_number] => 13/126532 [patent_app_country] => US [patent_app_date] => 2009-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 8315 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13126532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7680699 [patent_doc_number] => 20100105887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'PROCESS FOR THE PREPARATION OF GEMCITABINE HYDROCHLORIDE' [patent_app_type] => utility [patent_app_number] => 12/582955 [patent_app_country] => US [patent_app_date] => 2009-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3429 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105887.pdf [firstpage_image] =>[orig_patent_app_number] => 12582955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6592485 [patent_doc_number] => 20100130568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'TOPICAL COMPOSITIONS COMPRISING TELMESTEINE FOR TREATING DERMATOLOGICAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/575848 [patent_app_country] => US [patent_app_date] => 2009-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4412 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130568.pdf [firstpage_image] =>[orig_patent_app_number] => 12575848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6359131 [patent_doc_number] => 20100087386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'TOPICAL USE OF LEVOFLOXACIN FOR REDUCING LUNG INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 12/574666 [patent_app_country] => US [patent_app_date] => 2009-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10811 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20100087386.pdf [firstpage_image] =>[orig_patent_app_number] => 12574666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6113084 [patent_doc_number] => 20110190233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'ANIONIC CONJUGATES OF GLYCOSYLATED BACTERIAL METABOLITE' [patent_app_type] => utility [patent_app_number] => 13/122428 [patent_app_country] => US [patent_app_date] => 2009-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32425 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190233.pdf [firstpage_image] =>[orig_patent_app_number] => 13122428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6136421 [patent_doc_number] => 20110009372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'Compounds and compositions' [patent_app_type] => utility [patent_app_number] => 12/571060 [patent_app_country] => US [patent_app_date] => 2009-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 168156 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009372.pdf [firstpage_image] =>[orig_patent_app_number] => 12571060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9239400 [patent_doc_number] => 08604192 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Cyclohexenyl nucleic acids analogs' [patent_app_type] => utility [patent_app_number] => 13/063917 [patent_app_country] => US [patent_app_date] => 2009-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26763 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13063917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7651852 [patent_doc_number] => 20110301121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'HYDROGEL OF POLYSACCHARIDE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 13/202234 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5807 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301121.pdf [firstpage_image] =>[orig_patent_app_number] => 13202234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9503761 [patent_doc_number] => 08742077 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-03 [patent_title] => 'Method for preparing 1,6:2,3-dianhydro-β-D-mannopyranose' [patent_app_type] => utility [patent_app_number] => 13/119326 [patent_app_country] => US [patent_app_date] => 2009-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3005 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13119326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6374554 [patent_doc_number] => 20100075923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'METHOD OF ENHANCING TGF-BETA SIGNALLING' [patent_app_type] => utility [patent_app_number] => 12/560136 [patent_app_country] => US [patent_app_date] => 2009-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7458 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20100075923.pdf [firstpage_image] =>[orig_patent_app_number] => 12560136 [rel_patent_id] =>[rel_patent_doc_number] =>)